These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

367 related items for PubMed ID: 18450115

  • 21. Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3.
    Chen W, Jin W, Hardegen N, Lei KJ, Li L, Marinos N, McGrady G, Wahl SM.
    J Exp Med; 2003 Dec 15; 198(12):1875-86. PubMed ID: 14676299
    [Abstract] [Full Text] [Related]

  • 22. TLR2 agonists enhance CD8+Foxp3+ regulatory T cells and suppress Th2 immune responses during allergen immunotherapy.
    Tsai YG, Yang KD, Niu DM, Chien JW, Lin CY.
    J Immunol; 2010 Jun 15; 184(12):7229-37. PubMed ID: 20483759
    [Abstract] [Full Text] [Related]

  • 23. Augmentation of regulatory T cells in allergic individuals by recombinant Der f 2 peptide with fungal immunomodulatory peptide fve.
    Wu CC, Liao EC, Lee MF, Tsai JJ.
    Ann Allergy Asthma Immunol; 2009 Mar 15; 102(3):216-22. PubMed ID: 19354068
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Responses of CD4(+) CD25(+) Foxp3(+) and IL-10-secreting type I T regulatory cells to cluster-specific immunotherapy for allergic rhinitis in children.
    Lou W, Wang C, Wang Y, Han D, Zhang L.
    Pediatr Allergy Immunol; 2012 Mar 15; 23(2):140-9. PubMed ID: 22192331
    [Abstract] [Full Text] [Related]

  • 26. [Clinical efficacy of a standardized specific immunotherapy against house dust mite in 85 asthmatic children].
    Zhang X, Li MR, Wang C, Wang XN, Zhang HL, Lin J, Jin K, Li YC.
    Zhonghua Er Ke Za Zhi; 2010 Jul 15; 48(7):526-30. PubMed ID: 21055090
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Quantitation of canine regulatory T cell populations, serum interleukin-10 and allergen-specific IgE concentrations in healthy control dogs and canine atopic dermatitis patients receiving allergen-specific immunotherapy.
    Keppel KE, Campbell KL, Zuckermann FA, Greeley EA, Schaeffer DJ, Husmann RJ.
    Vet Immunol Immunopathol; 2008 Jun 15; 123(3-4):337-44. PubMed ID: 18423890
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Continuous avoidance measures with or without acaricide in dust mite-allergic asthmatic children.
    Bahir A, Goldberg A, Mekori YA, Confino-Cohen R, Morag H, Rosen Y, Monakir D, Rigler S, Cohen AH, Horev Z, Noviski N, Mandelberg A.
    Ann Allergy Asthma Immunol; 1997 May 15; 78(5):506-12. PubMed ID: 9164365
    [Abstract] [Full Text] [Related]

  • 33. Contribution of regulatory T cells to alleviation of experimental allergic asthma after specific immunotherapy.
    Maazi H, Shirinbak S, Willart M, Hammad HM, Cabanski M, Boon L, Ganesh V, Baru AM, Hansen G, Lambrecht BN, Sparwasser T, Nawijn MC, van Oosterhout AJ.
    Clin Exp Allergy; 2012 Oct 15; 42(10):1519-28. PubMed ID: 22994349
    [Abstract] [Full Text] [Related]

  • 34. Cytokine production, activation marker, and skin homing receptor in children with atopic dermatitis and bronchial asthma.
    Antúnez C, Torres MJ, Mayorga C, Corzo JL, Jurado A, Santamaría-Babi LF, Vera A, Blanca M.
    Pediatr Allergy Immunol; 2006 May 15; 17(3):166-74. PubMed ID: 16672002
    [Abstract] [Full Text] [Related]

  • 35. The association of CTLA-4 and HLA class II autoimmune risk genotype with regulatory T cell marker expression in 5-year-old children.
    Jonson CO, Hedman M, Karlsson Faresjö M, Casas R, Ilonen J, Ludvigsson J, Vaarala O, ABIS Study Group.
    Clin Exp Immunol; 2006 Jul 15; 145(1):48-55. PubMed ID: 16792673
    [Abstract] [Full Text] [Related]

  • 36. Preparation of functionally preserved CD4+ CD25high regulatory T cells from leukapheresis products from ulcerative colitis patients, applicable to regulatory T-cell transfer therapy.
    Sumida Y, Nakamura K, Kanayama K, Akiho H, Teshima T, Takayanagi R.
    Cytotherapy; 2008 Jul 15; 10(7):698-710. PubMed ID: 18985477
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Safety and immunogenicity of a cluster specific immunotherapy in children with bronchial asthma and mite allergy.
    Schubert R, Eickmeier O, Garn H, Baer PC, Mueller T, Schulze J, Rose MA, Rosewich M, Renz H, Zielen S.
    Int Arch Allergy Immunol; 2009 Jul 15; 148(3):251-60. PubMed ID: 18849616
    [Abstract] [Full Text] [Related]

  • 40. Role of interleukin-10 and transforming growth factor beta 1 in otitis media with effusion.
    Zhao SQ, Li J, Liu H, Zhang QG, Wang Y, Han DM.
    Chin Med J (Engl); 2009 Sep 20; 122(18):2149-54. PubMed ID: 19781301
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.